These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3873420

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunopharmacological profile of HWA 486, a novel isoxazol derivative--II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A.
    Bartlett RR.
    Int J Immunopharmacol; 1986; 8(2):199-204. PubMed ID: 3486841
    [Abstract] [Full Text] [Related]

  • 3. Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis.
    Pasternak RD, Wadopian NS, Wright RN, Siminoff P, Gylys JA, Buyniski JP.
    Agents Actions; 1987 Aug; 21(3-4):241-3. PubMed ID: 3500589
    [Abstract] [Full Text] [Related]

  • 4. 6-Sulfanilamidoindazole arthritis in rats: influence of the new anti-inflammatory agent CGP 28237 and of the immunomodulating compound HWA 486 on degree of arthritis and on acute phase reaction.
    Hirschelmann R, Schade R.
    Pharmazie; 1988 Jan; 43(1):54. PubMed ID: 3131786
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
    Magari K, Miyata S, Nishigaki F, Ohkubo Y, Mutoh S.
    Inflamm Res; 2004 Oct; 53(10):544-50. PubMed ID: 15597149
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide.
    Yamaguchi T, Kakefuda R, Tanimoto A, Watanabe Y, Tajima N.
    Inflamm Res; 2012 May; 61(5):445-54. PubMed ID: 22245957
    [Abstract] [Full Text] [Related]

  • 10. Antiarthritic and immunoregulatory activity of spirogermanium.
    DiMartino MJ, Lee JC, Badger AM, Muirhead KA, Mirabelli CK, Hanna N.
    J Pharmacol Exp Ther; 1986 Jan; 236(1):103-10. PubMed ID: 2934544
    [Abstract] [Full Text] [Related]

  • 11. Effect of antirheumatic agents on the mitogen response of arthritic rat spleen cells.
    Pasternak RD, Marks RL, Hubbs SJ, DiPasquale G.
    Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):353-67. PubMed ID: 3927458
    [Abstract] [Full Text] [Related]

  • 12. Arthritis in MRL/LPR mice and in collagen II sensitized DBA-1 mice and their use in pharmacology.
    Rordorf C, Pataki A, Nogues V, Schlager F, Feige U, Glatt M.
    Int J Tissue React; 1987 Jun; 9(4):341-7. PubMed ID: 3623829
    [Abstract] [Full Text] [Related]

  • 13. Immunomodulation of proteoglycan-induced progressive polyarthritis by leflunomide.
    Glant TT, Mikecz K, Bartlett RR, Deák F, Thonar EJ, Williams JM, Mattar T, Kuettner KE, Schleyerbach R.
    Immunopharmacology; 1992 Jun; 23(2):105-16. PubMed ID: 1601639
    [Abstract] [Full Text] [Related]

  • 14. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs.
    Connolly KM, Stecher VJ, Danis E, Pruden DJ, LaBrie T.
    Agents Actions; 1988 Aug; 25(1-2):94-105. PubMed ID: 3142230
    [Abstract] [Full Text] [Related]

  • 15. Immunomodulation of rat antigen-induced arthritis by leflunomide alone and in combination with cyclosporin A.
    Thoss K, Henzgen S, Petrow PK, Katenkamp D, Brauer R.
    Inflamm Res; 1996 Feb; 45(2):103-7. PubMed ID: 8907592
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
    Bloxham DP, Bradshaw D, Cashin CH, Dodge BB, Lewis EJ, Westmacott D, Self CR.
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1331-40. PubMed ID: 2156999
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.